Aspen Pharmacare Holdings (JSE:APN) PE Ratio (TTM): At Loss (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JSE:APN Aspen Pharmacare Holdings Ltd JSE:APN
72 GF Score
Price R150.32
GF Value R170.84
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-19), Aspen Pharmacare Holdings's share price is R150.32. Aspen Pharmacare Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was R-4.51. Therefore, Aspen Pharmacare Holdings's PE Ratio (TTM) for today is At Loss.


The historical rank and industry rank for Aspen Pharmacare Holdings's PE Ratio (TTM) or its related term are showing as below:

JSE:APN' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: 15.96   Max: 40.2
Current: At Loss


During the past 13 years, the highest PE Ratio (TTM) of Aspen Pharmacare Holdings was 40.20. The lowest was 0.00. And the median was 15.96.


JSE:APN's PE Ratio (TTM) is ranked worse than
100% of 639 companies
in the Drug Manufacturers industry
Industry Median: 20.97 vs JSE:APN: At Loss

Aspen Pharmacare Holdings's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was R3.31. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was R-4.51.

As of today (2026-07-19), Aspen Pharmacare Holdings's share price is R150.32. Aspen Pharmacare Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was R9.30. Therefore, Aspen Pharmacare Holdings's PE Ratio without NRI for today is 16.16.

During the past 13 years, Aspen Pharmacare Holdings's highest PE Ratio without NRI was 30.08. The lowest was 5.16. And the median was 12.04.

Aspen Pharmacare Holdings's EPS without NRI for the six months ended in Dec. 2025 was R3.84. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was R9.30.

During the past 12 months, Aspen Pharmacare Holdings's average EPS without NRI Growth Rate was -29.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -13.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -0.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 0.10% per year.

During the past 13 years, Aspen Pharmacare Holdings's highest 3-Year average EPS without NRI Growth Rate was 365.50% per year. The lowest was -13.40% per year. And the median was 17.85% per year.

Aspen Pharmacare Holdings's EPS (Basic) for the six months ended in Dec. 2025 was R3.31. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was R-4.51.


Aspen Pharmacare Holdings  (JSE:APN) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Aspen Pharmacare Holdings PE Ratio (TTM) Related Terms


Aspen Pharmacare Holdings PE Ratio (TTM) Historical Data

* Premium members only.

The historical data trend for Aspen Pharmacare Holdings's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings PE Ratio (TTM) Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.39 9.71 15.60 23.53 At Loss

Aspen Pharmacare Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss 23.53 At Loss At Loss At Loss

JSE:APN vs ZTS, UTHR, VTRS: PE Ratio (TTM) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings PE Ratio (TTM) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's PE Ratio (TTM) falls into.


JSE:APN
72GF Score
Aspen Pharmacare Holdings Ltd JSE:APN
PE Ratio (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Aspen Pharmacare Holdings's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=150.32/-4.505
=At Loss

Aspen Pharmacare Holdings's Share Price of today is R150.32.
For company reported semi-annually, Aspen Pharmacare Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was R-4.51.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Is Aspen Pharmacare Holdings (JSE:APN) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of R150.32 is trading 12% below its estimated GF Value™ of R170.84. GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.

Key valuation signals for JSE:APN:

  • PE Ratio (TTM): At Loss
  • GF Value™: R170.84 vs. price of R150.32 (12% below fair value)
  • GF Score™: 72/100 with 10 warning signs

No single metric tells the full story. See the JSE:APN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
72GF Score

Get the complete analysis for JSE:APN

PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R150.32
Price
R170.84
GF Value